Hoppa till innehållet

Redeye: BONESUPPORT Q1 - Short-sighted reaction on solid report

Redeye is encouraged to see a slightly higher-than-expected sales development for US CERAMENT G and a strong EBIT margin, cementing the thesis of a profitable high-sales growth journey ahead. We make no changes to our base case, which we expect to be reached in the coming 12 months.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera